Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-23

Clinical Trial Update: Sulforadex in Healthy Volunteers SAD [Phase 1]

View source ↗

Summary

Phase 1 single-ascending-dose study of Sulforadex in healthy volunteers has completed; the trial lists stage prostate cancer as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulforadex

Snippet

Sponsor: Evgen Pharma | Conditions: Stage, Prostate Cancer | Phase 1 | Status: COMPLETED